(Q44318882)

1 December 2017

Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice (English)

1 reference

1 December 2017

0 references

0 references

0 references

0 references

Audrey L Hildebrandt

1

1 reference

1 December 2017

Dawn M Kelly-Sullivan

series ordinal

2

1 reference

1 December 2017

Shawn C Black

series ordinal

3

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

European Journal of Pharmacology

1 December 2017

1 reference

1 December 2017

462

1 reference

1 December 2017

125-132

1 reference

1 December 2017

1-3

1 reference

Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors.

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901343-8

Appetite suppression and weight loss after the cannabinoid antagonist SR 141716.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901343-8

Valvular heart disease associated with fenfluramine-phentermine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901343-8

Appetite suppressants and valvular heart disease - a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901343-8

Leptin-regulated endocannabinoids are involved in maintaining food intake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901343-8

Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901343-8

Complex regional haemodynamic effects of anandamide in conscious rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901343-8

123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901343-8

Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901343-8

2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901343-8

Validation of a high-resolution X-ray computed tomography system to measure murine adipose tissue depot mass in situ and longitudinally.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901343-8

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901343-8

The worldwide obesity epidemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901343-8

Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901343-8

Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901343-8

Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901343-8

Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901343-8

Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901343-8

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901343-8

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901343-8

Reversal of Phen-Fen associated valvular regurgitation documented by serial echocardiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901343-8

Obesity: an epidemic in need of therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901343-8

Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901343-8

Hyperphagia in pre-fed rats following oral delta9-THC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901343-8

10.1016/S0014-2999(03)01343-8

7 January 2021

Identifiers

DOI

1 reference

release_3q5w4yqxznhczng3u75thlpxri

1 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3q5w4yqxznhczng3u75thlpxri

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference